Juggle With Console-Anytime and Anywhere
Comparison of STRATYX™ to other 250mL bioreactors in a fed-batch CHO process.
Culture Biosciences Announces Strategic Addition to Its Board of Directors to Accelerate Hardware Commercialization and SaaS Growth
Break Free from the Bioprocess Juggling Act
Smart Solutions for Bioprocessing, Accelerating Results Using Cloud-Connected Bioreactors
Accelerating Plasmid Construct Development with Smart Bioreactors
Stratyx™ 250 Inline Viable Cell Density Measurement
Bioprocess Development, Anytime Anywhere: Inside Culture’s Nexxys™ Platform
Advanced Therapies Week 2026: Demonstrating Bioprocessing Anytime, Anywhere
Culture Biosciences Announces Close of Series C Round to Accelerate Commercial Growth of Stratyx 250 and Console Platform
Xcell Biosciences and Culture Biosciences Partner to Advance Cell Therapy Quality Through AI and Machine Learning
Growth and Site to Site Comparison of a HEK Fed-Batch Process in Stratyx™ 250
Stratyx™ 250 Comparison of CHO Process Characteristics in 250mL Bioreactor Systems
Stratyx™ 250 Bioreactor Platform Overview
Culture Biosciences unveils Stratyx™ 250, the first cloud-integrated, mobile bioreactor for cell culture process development
Stratyx™ 250 Early Adopter Program
Welcoming Victor Bornsztejn as Senior Vice President of Commercial
Modeling and Online Estimation of kLa and P/V for 250mL and 5L Mammalian Bioreactors
Comparison of AAV2 production in Culture Biosciences’ 250mL reactors vs commercially available 250mL bioreactors
Unveiling True Growth and Production Rates: Precision Volume Accounting In Fed-Batch Cultures
Supplemental Bioreactor Capacity Accelerates Bioprocess Development
Accurate Cell Culture Characterization Enabled By Culture Biosciences’ Cloud Bioreactors
Scaling up mAb process development from 250mL to 5L bioreactor with consistent yield in Culture Biosciences cloud-connected bioreactors
Custom Built Off-Gas Analyzers for High-Throughput Fermentation
Ensuring Data Quality Through Mass Balance Calculations in Culture's Bioreactors
A Guide for Running Statistically-Powered Clone-Screening Experiments
Full Factorial DOEs for Multiple CHOZN® Cell Lines
A Reproducible and Scalable System for CHO Cell Culture
AAV9 Process Robustness Evaluation in Cloud-native 250mL Bioreactors
Culture Presents ThermoFisher Poster at BioProcess International in Boston
Culture Biosciences Appoints Chris Williams as Chief Executive Officer
Culture Biosciences and Google Cloud Announce Collaboration to Revolutionize Bioprocess Development
Scaling up HEK cell culture process from 250mL to 5L bioreactor with consistent performance in Culture Biosciences cloud-connected bioreactors
AAV Process Development in Culture Biosciences’ 250mL Bioreactors
High-throughput Screening of Next-Gen Small Molecule Enhancers and Process Automation in Cloud-Connected Bioreactors
Continuous monitoring with Culture Biosciences 250mL Bioreactors and 908 Devices MAVERICK
Culture Biosciences Joins Forces with Ginkgo Technology Network Partner
AAV Production in Culture Biosciences’ 250mL Bioreactors
Bakuchiol Synthesis Scale Up
Insights from the ESACT Bioprocess Modeling Course 2023
Culture Solutions: Systematic & Automated Analysis for Cell Line Screening
The Mysterious Case of the Missing Glucose
New Feature Release: Live Data in Console
Biotech Executive Beth Thompson-Webb Joins Culture Biosciences’ Board Of Directors
Culture Biosciences Establishes Advisory Board Of Biotech And Biopharma Executives To Guide The Corporate Strategy And Accelerate Growth
Surfing the Waves in Upstream Bioprocess Development – Molecule to Market Podcast with Culture’s CEO, Will Patrick
Significant CHOZN® Titer Gains: How MilliporeSigma Leveraged Nexxys and Culture’s Cloud Bioreactor Platform
Culture Biosciences Focuses Technology And Service Platform On Biologics
InSiliCHO: Modeling Cell Line Dynamics for Process Development
Launching Culture’s 5L Reactors: An Interview with CEO Will Patrick
Making Bioengineering a Reality: Culture Enables Sestina’s New SynBio Platform
Culture Biosciences Raises $80m Series B To Tackle Demand For Large-Scale Biomanufacturing
Why Joyn Bio Won’t Build a High-Throughput Fermentation Lab
The Biggest Challenges of Bioprocessing and How to Overcome Them
Culture Named One Of “10 Start-Ups To Watch” By C&En
No More “What Ifs” - How Nektar Takes the Guesswork Out of Scaling Bioprocesses
Best Practices in Bio Fermentation Process Development
Building a Better Bioreactor: an Interview with our CTO, Matt Ball
High-Throughput DoE Of 52 Parallel Bioreactors Doubles Titer In 1 Week
Analyze All Your High-Throughput Bioreactor Data in the Cloud
The Every Company™ Approaches Scaling Up By Scaling Down
Fixing Nitrogen: Cleaner Agriculture Through Microbial Fertilizers
Drones To Bioreactors: CDMO Culture Biosciences Ready To Fly High
Bay Area Biotech Culture Biosciences Reels In $5.5m In Funding
Two Former Members Of Google’s Skunkworks Division Have Launched A Biomanufacturing Company
A New Lab Is Brewing Microbes To Create Makeup And Medicines
.png?width=500&height=500&name=Bionova-WP-Thumbnail%20(1).png)
.png?width=500&height=500&name=MikeStapelton%20(1).png)
.png?width=500&height=500&name=Octopus-Video-Final%20(1).png)
.png?width=500&height=500&name=Untitled%20design%20(2).png)
.png?width=500&height=500&name=Untitled%20design%20(1).png)
.png?width=500&height=500&name=031974f5-13da-402b-a6a6-dd5b88dbde09%20(1).png)
.png?width=500&height=500&name=6939d31802fbcbdebdf5b1b0_TCulture%20Biosciences%20%26%20XcellBio%20Announce%20Partnership%20(1).png)
.png?width=500&height=500&name=69416534315795685bee8521_Series%20C%20(3).png)
.png?width=500&height=500&name=67e835ae888006cd086a6a7a_Stratyx%E2%84%A2%20250%20Bioreactor%20Platform%20Overview%20(2).png)
.png?width=500&height=500&name=67e8369af64a60535b97367e_Stratyx%E2%84%A2%20250%20Early%20Adopter%20Program%20(1).png)
.png?width=500&height=500&name=66df5c65ea79e8c5083da407_Google-Partnership-Press-Release-Image-v5-1200x628%20(1).png)
